Related references
Note: Only part of the references are listed.Anti-inflammatory cytokines IL-35 and IL-10 block atherogenic lysophosphatidylcholine-induced, mitochondrial ROS-mediated innate immune activation, but spare innate immune memory signature in endothelial cells
Xinyuan Li et al.
REDOX BIOLOGY (2020)
Roles of prostaglandins in tumor-associated lymphangiogenesis with special reference to breast cancer
Peeyush K. Lala et al.
CANCER AND METASTASIS REVIEWS (2018)
NOX4-driven ROS formation regulates proliferation and apoptosis of gastric cancer cells through the GLI1 pathway
Chao-Tao Tang et al.
CELLULAR SIGNALLING (2018)
NADPH oxidase 4 regulates anoikis resistance of gastric cancer cells through the generation of reactive oxygen species and the induction of EGFR
Shangce Du et al.
CELL DEATH & DISEASE (2018)
Nox4 Overexpression as a Poor Prognostic Factor in Patients with Oral Tongue Squamous Cell Carcinoma Receiving Surgical Resection
Yen-Hao Chen et al.
JOURNAL OF CLINICAL MEDICINE (2018)
CCR10 activation stimulates the invasion and migration of breast cancer cells through the ERK1/2/MMP-7 signaling pathway
Hao-yu Lin et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2017)
Overexpression of NOX4 predicts poor prognosis and promotes tumor progression in human colorectal cancer
Xiao-Lu Lin et al.
ONCOTARGET (2017)
Crosstalk between cancer cells and blood endothelial and lymphatic endothelial cells in tumour and organ microenvironment
Esak Lee et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2015)
The human Nox4: gene, structure, physiological function and pathological significance
Shuhui Guo et al.
JOURNAL OF DRUG TARGETING (2015)
The role of CCL21/CCR7 chemokine axis in breast cancer-induced lymphangiogenesis
Elena Tutunea-Fatan et al.
MOLECULAR CANCER (2015)
NADPH Oxidase NOX4 Supports Renal Tumorigenesis by Promoting the Expression and Nuclear Accumulation of HIF2α
Jennifer L. Gregg et al.
CANCER RESEARCH (2014)
NOX4 promotes non-small cell lung cancer cell proliferation and metastasis through positive feedback regulation of PI3K/Akt signaling
Cuixiang Zhang et al.
ONCOTARGET (2014)
Lymphangiogenesis and lymphatic vessel remodelling in cancer
Steven A. Stacker et al.
NATURE REVIEWS CANCER (2014)
Inhibiting cancer metastasis via targeting NAPDH oxidase 4
Biao Zhang et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Targeting NADPH oxidases for the treatment of cancer and inflammation
Michael Y. Bonner et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2012)
RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2-Negative, Locally Recurrent or Metastatic Breast Cancer
Nicholas J. Robert et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
ROS generation via NOX4 and its utility in the cytological diagnosis of urothelial carcinoma of the urinary bladder
Keiji Shimada et al.
BMC UROLOGY (2011)
NADPH oxidase 4 is an oncoprotein localized to mitochondria
Kelly A. Graham et al.
CANCER BIOLOGY & THERAPY (2010)
Lymphangiogenesis: Molecular Mechanisms and Future Promise
Tuomas Tammela et al.
CELL (2010)
Phase III Study of Bevacizumab Plus Docetaxel Compared With Placebo Plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer
David W. Miles et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Correlation effect of EGFR and CXCR4 and CCR7 chemokine receptors in predicting breast cancer metastasis and prognosis
Yixin Liu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
Lymphangiogenesis: A new player in cancer progression
Masayuki Nagahashi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
NADPH Oxidase 4 Contributes to Transformation Phenotype of Melanoma Cells by Regulating G2-MCell Cycle Progression
Maki Yamaura et al.
CANCER RESEARCH (2009)
Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype
Binod Kumar et al.
CANCER RESEARCH (2008)
Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Kathy Miller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites
Satoshi Hirakawa et al.
BLOOD (2007)
Tumor metastasis: mechanistic insights and clinical challenges
Patricia S. Steeg
NATURE MEDICINE (2006)
CCR7 and CXCR4 as novel biomarkers predicting axillary lymph node metastasis in T1 breast cancer
N Cabioglu et al.
CLINICAL CANCER RESEARCH (2005)
Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer
Y Nakamura et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins
MJ Karkkainen et al.
NATURE IMMUNOLOGY (2004)
VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors
MMT Mattila et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice
T Veikkola et al.
EMBO JOURNAL (2001)
Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis
M Skobe et al.
NATURE MEDICINE (2001)
Microvessels that predict axillary lymph node metastases in patients with breast cancer
SD Nathanson et al.
ARCHIVES OF SURGERY (2000)
Share Paper
